Mydecine Unveils Four Psychedelic Drug Candidates

By Natan Ponieman8 days ago


Mydecine Innovations Group (OTC: MYCOF), a Denver-based psychedelics research company, announced its four lead novel drug candidates on Wednesday.

The company plans to present the candidates at Pre-Investigational New Drug meetings with the FDA and Health Canada, a necessary step in obtaining approval for drug development and clinical trials.

“We are essentially taking the value that is currently present in natural molecules, such as the ...

Continue read on